- 1. (E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene Methanamine
- [A synthetic allylamine derivative with antifungal activity. Terbinafine exerts its effect through inhibition of squalene epoxidase, thereby blocking the biosynthesis of ergosterol, an important component of fungal cell membranes. As a result, this agent disrupts fungal cell membrane synthesis and inhibits fungal growth. ( NCI )] (UMLS (NCI) C0076110) =Organic Chemical; Pharmacologic Substance =[AM700] ANTIFUNGALS;
naphthalene;
[DE102] ANTIFUNGAL, TOPICAL;
=(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine Hydrochloride | - 51. Endocardium
- (UMLS (HL7) C1550632) =Body Substance =SpecimenEntityType;
|
- 2. (E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine Hydrochloride
- [A synthetic allylamine derivative structurally related to naftifine, antifungal Terbinafine Hydrochloride blocks ergosterol biosynthesis by inhibition of squalene epoxidase, part of the sterol synthesis pathway for the fungal cell membrane. Highly lipophilic, it tends to accumulate in skin, nails, and fatty tissues. Terbinafine is active against dermatophytes. (NCI04) ( NCI )] (UMLS (NCI) C0771029) Terbinafine Hydrochloride;
TERBINAFINE HYDROCHLORIDE PREPARATION =Organic Chemical; Pharmacologic Substance =(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene Methanamine;
=TERBINAFINE HYDROCHLORIDE 1 %;
TERBINAFINE HYDROCHLORIDE 250 MG | - 52. Endocervical
- (UMLS (HL7) C1550252) =Body Part, Organ, or Organ Component =Body Part;
|
- 3. end
- [Condition is tested at the end of a repeated service execution. The service is repeated only if the condition is true (DO service WHILE condition). ( HL7V3.0 )] (UMLS (HL7) C1561490) =Functional Concept =ActRelationshipCheckpoint;
| - 53. ENDOCERVICAL BIOPSY
- [Removal of tissue from the endocervix for microscopic examination. ( NCI )] (UMLS (ICD9CM) C0195343) =Diagnostic Procedure
|
- 4. end brain
- [ ] (UMLS (CSP) C1537012) =Body Part, Organ, or Organ Component
| - 54. endocervical curettage
- [(en-do-SER-vih-kul kyoo-reh-TAHZH) The scraping of the mucous membrane of the cervical canal using a spoon-shaped instrument called a curette. ( NCI )] (UMLS (NCI) C0195344) =Therapeutic or Preventive Procedure
|
- 5. end of life care
- [(HOS-pis) A program that provides special care for people who are near the end of life and for their families, either at home, in freestanding facilities, or within hospitals. ( NCI )] (UMLS (CSP) C0085555) =Health Care Activity ;
| - 55. Endocervical Mass
- (UMLS (NCI) C0743505) =Anatomical Abnormality
|
- 6. End Point
- [A place of termination or completion. This may be a primary or secondary outcome variable used to judge the effectiveness of a treatment. ( NCI )] (UMLS (NCI) C0162488) =Qualitative Concept
| - 56. Endocervical Polyp
- (UMLS (NCI) C0014126) =Neoplastic Process ;
|
- 7. End related service request(s), end current service request.
- (UMLS (HL7) C1548959) =Intellectual Product =Sequence Condition Code;
| - 57. EndocervicalRoute
- [Endocervical ( HL7V3.0 )] (UMLS (HL7) C1699454) =Functional Concept =RouteBySite;
=Injection, amniotic fluid;
Injection, biliary tract;
|
- 8. End related service request(s), start current service request.
- (UMLS (HL7) C1548960) =Intellectual Product =Sequence Condition Code;
| - 58. Endocervicitis
- (UMLS (NCI) C0014127) =Disease or Syndrome ;
|
- 9. End state
- [The HL7 MDF says that leaf level use cases should be connected to a state transition of the subject class. The use case diagram provides the link to the subject class. The modeler must use three properties to identify the state transition — this property and the two following ones named StartState and StateTransition. The first two are, as their names imply, the names of the starting state and ending state of the transition, and the third is the name of the transition. ( HL7V3.0 )] (UMLS (HL7) C1554156) =Idea or Concept =HL7DefinedRoseProperty;
| - 59. Endocervix
- (UMLS (NCI) C0227837) =Body Part, Organ, or Organ Component
|
- 10. End Too Late Alert
- [Proposed therapy may be inappropriate or ineffective because the end of administration is too close to another planned therapy ( HL7V3.0 )] (UMLS (HL7) C1555554) =Intellectual Product =TimingDetectedIssueCode;
| - 60. Endocrine
- [Collective designation for those tissues capable of secreting hormones. ( NCI )] (UMLS (NCI) C0521425) =Functional Concept
|
- 11. End-of-life Nursing
- [Nursing specialized in providing palliative care for terminally ill patients. It includes support for both the patient and their family. ( NCI )] (UMLS (NCI) C0557533) =Biomedical Occupation or Discipline
| - 61. Endocrine and metabolic disturbances specific to the fetus and newborn
- [ ] (UMLS (ICD9CM) C0158979) =Disease or Syndrome ;
|
- 12. End-Stage Renal Disease (ESRD) Treatment
- (UMLS (HL7) C1552425) =Intellectual Product ;
=Clinic/Center;
| - 62. endocrine cancer
- [Cancer that occurs in endocrine tissue, the tissue in the body that secretes hormones. ( NCI )] (UMLS (CSP) C0153658) =Neoplastic Process
|
- 13. End-to-Side Anastomosis
- (UMLS (NCI) C0332857) =Therapeutic or Preventive Procedure
| - 63. Endocrine Cell
- (UMLS (NCI) C0229525) =Cell
|
- 14. endarterectomy
- [surgical excision of the atheromatous tunica intima of an artery. ( CSP )] (UMLS (CSP) C0014098) =Therapeutic or Preventive Procedure ;
=revascularization surgery;
| - 64. Endocrine Cell of Gut
- [A hormone-secreting cell present in the epithelium of the intestine. ( NCI )] (UMLS (NCI) C0524979) =Cell ;
|
- 15. ENDARTERECTOMY NOS
- [ ] (UMLS (ICD9CM) C0375949) =Therapeutic or Preventive Procedure
| - 65. Endocrine Disease
- [impairment of health or a condition of abnormal functioning of the system of glands that release their secretions (hormones) directly into the circulatory system. ( CSP )] (UMLS (NCI) C0014130) =Disease or Syndrome ;
=Disease;
Diseases, Manifestations or Physiologic States =adrenal disorder;
dwarfism;
Endocrine Gland Neoplasms;
gonad disorder;
Diseases of pancreas;
Disorders of parathyroid gland;
Pituitary Diseases;
PCOS;
precocious puberty;
DISORDER OF THYROID NOS;
adrenal disorder;
Breast Disease;
Diabete mellito;
dwarfism;
Endocrine Gland Neoplasms;
gonad disorder;
hyperinsulinemia;
Disorders of parathyroid gland;
Pituitary Diseases;
PERSIST HYPERPLAS THYMUS;
DISORDER OF THYROID NOS;
Tuberculosis, Endocrine;
Polyendocrinopathies, Autoimmune |
- 16. ENDARTERECTOMY OF AORTA
- [ ] (UMLS (ICD9CM) C0190305) =Therapeutic or Preventive Procedure
| - 66. Endocrine Disorder Arising from Mental Factor
- (UMLS (NCI) C0154558) =Disease or Syndrome
|
- 17. Endarterectomy of intracranial vessels
- [ ] (UMLS (ICD9CM) C0176628) =Therapeutic or Preventive Procedure
| - 67. endocrine disorder chemotherapy
- [application of the beneficial effects of drugs to control or cure of the system of glands that release their secretions (hormones) directly into the circulatory system. ( CSP )] (UMLS (CSP) C0596510) =Therapeutic or Preventive Procedure ;
=chemotherapy;
|
- 18. Endarterectomy of lower limb arteries
- (UMLS (ICD9CM) C0190863) =Therapeutic or Preventive Procedure
| - 68. endocrine disorder diagnosis
- [determination of disorder of the endocrine system (an impairment of health or a condition of abnormal functioning of the system of glands that release their secretions (hormones) directly into the circulatory system) based on symptoms, medical history, risk factors, and clinical tests. ( CSP )] (UMLS (CSP) C0011909) =Diagnostic Procedure =Diagnosed;
=pituitary disorder diagnosis;
|
- 19. Endarterectomy of other thoracic vessels
- [ ] (UMLS (ICD9CM) C0176631) =Therapeutic or Preventive Procedure
| - 69. ENDOCRINE DISORDERS NEC
- [ ] (UMLS (ICD9CM) C1961110) Other specified endocrine disorders;
=Disease or Syndrome ;
|
- 20. Endarterectomy of other vessels of head and neck
- [ ] (UMLS (ICD9CM) C0176629) =Therapeutic or Preventive Procedure
| - 70. endocrine disrupting compound
- [exogenous agent that mimics endogenous hormones, or interferes with the production, release, transport, metabolism, binding, action or elimination of natural hormones in the body responsible for the maintenance of homeostasis and the regulation of developmental processes. ( CSP )] (UMLS (CSP) C1568245) endocrine disruptor;
=Hazardous or Poisonous Substance; ;
=Chemical;
|
- 21. Endarterectomy of upper limb vessels
- [ ] (UMLS (ICD9CM) C0176630) =Therapeutic or Preventive Procedure
| - 71. ENDOCRINE DX PROC NEC
- [ ] (UMLS (ICD9CM) C0176121) =Diagnostic Procedure
|
- 22. Endarteritis
- [Inflammation of the inner endothelial lining (TUNICA INTIMA) of an artery. ( MSH )] (UMLS (NCI) C0014100) =Disease or Syndrome ;
=arteritis;
| - 72. Endocrine exophthalmos
- [ ] (UMLS (ICD9CM) C0155264) =Disease or Syndrome ;
|
- 23. Endemic African Kaposi Sarcoma
- [A Kaposi sarcoma that occurs in adults and children in Equatorial Africa. ( NCI )] (UMLS (NCI) C1333384) Endemic African Kaposi's Sarcoma =Neoplastic Process
| - 73. endocrine gland
- [Ductless glands that secrete substances which are released directly into the circulation and which influence metabolism and other body functions. ( NCI )] (UMLS (CSP) C0014133) =Body Part, Organ, or Organ Component ;
|
- 24. Endemic Goiter
- [A form of IODINE deficiency disorders characterized by an enlargement of the THYROID GLAND in a significantly large fraction of a POPULATION GROUP. Endemic goiter is common in mountainous and iodine-deficient areas of the world where the DIET contains insufficient amount of iodine. ( MSH )] (UMLS (NCI) C0018022) =Disease or Syndrome ;
=Bocio (excl T85 T86);
| - 74. Endocrine Gland Secretion
- [chemical substances having a specific regulatory effect on the activity of a certain organ or organs, especially substances secreted by various endocrine glands and transported in the bloodstream to the target organs. ( CSP )] (UMLS (NCI) C0019932) =Hormone ;
=cell communication molecule;
=invertebrate hormone;
pheromone;
phytohormone;
Thyroid Gland Hormone;
steroid hormone;
neurohormone;
Peptide Hormone;
reproductive hormone;
selective estrogen receptor modulator |
- 25. ENDO IMP GRFT THOR AORTA
- [ ] (UMLS (ICD9CM) C1561903) Endovascular implantation of graft in thoracic aorta;
=Therapeutic or Preventive Procedure | - 75. Endocrine Ovary
- (UMLS (NCI) C1266874) =Body Part, Organ, or Organ Component
|
- 26. ENDO IMPL GRFT ABD AORTA
- (UMLS (ICD9CM) C0994526) Endovascular implantation of graft in abdominal aorta =Therapeutic or Preventive Procedure ;
| - 76. Endocrine Pancreas
- [irregular microscopic structures, varying from a few to hundreds of cells, scattered throughout the pancreas and comprising its endocrine portion; cell types include: alpha, secreting glucagon; beta, secreting insulin; delta, secreting somatostatin; and PP, secreting pancreatic polypeptide. ( CSP )] (UMLS (NCI) C0022131) =Body Part, Organ, or Organ Component =Gastrointestinal Tract, Pancreas;
|
- 27. ENDO INSRT BRONC DEF/SUB
- [ ] (UMLS (ICD9CM) C1719374) Endoscopic insertion of other bronchial device or substances =Diagnostic Procedure; Therapeutic or Preventive Procedure
| - 77. Endocrine Pancreas Disease
- [deviation from or interruption of the normal structure or function of the pancreatic islet. ( CSP )] (UMLS (NCI) C0271633) =Disease or Syndrome =Diseases of pancreas;
=Diabete mellito;
hyperinsulinemia;
Blood Glucose, Low;
hyperglucagonemia;
pancreatic islet hyperplasia;
pancreatic islet neoplasm |
- 28. ENDO INSRT/REPL BRON VAL
- [ ] (UMLS (ICD9CM) C1719370) Endoscopic insertion or replacement of bronchial valve(s) =Diagnostic Procedure; Therapeutic or Preventive Procedure
| - 78. endocrine pharmacology
- [study of the origin, nature, properties, and actions of drugs and their effects on the endocrine system; use this term mainly for intended, desired effects. ( CSP )] (UMLS (CSP) C0596511) =Biomedical Occupation or Discipline ;
=Pharmacologic;
|
- 29. ENDO POLPECTOMY LRGE INT
- (UMLS (ICD9CM) C0192894) =Therapeutic or Preventive Procedure
| - 79. Endocrine Physiology
- [Study of the functions and activities of the endocrine system as a whole or of any of its parts. ( NCI )] (UMLS (NCI) C0678896) =Physiologic Function ;
|
- 30. ENDO REM BRONCH DEVC/SUB
- [ ] (UMLS (ICD9CM) C1719373) Endoscopic removal of bronchial device(s) or substances =Diagnostic Procedure; Therapeutic or Preventive Procedure
| - 80. endocrine surgery
- [procedures performed on the endocrine system or any portion of it, used in the treatment of disease, injuries, or deformities; heading term for surgery involving endocrine glands. ( CSP )] (UMLS (CSP) C0038900) =Therapeutic or Preventive Procedure =Operation;
=Adrenal Gland Excision;
Bilateral orchiectomy;
Excision of the Hypophysis;
female castration;
Excision of the Pancreas;
thyroidectomy;
parathyroidectomy;
endocrine transplantation;
|
- 31. ENDO REM OBS HD/NECK VES
- [ ] (UMLS (ICD9CM) C1719716) Endovascular removal of obstruction from head and neck vessel(s) =Therapeutic or Preventive Procedure
| - 81. Endocrine Syndrome
- (UMLS (NCI) C1333387) =Disease or Syndrome
|
- 32. ENDO REPAIR OTHER VESSEL
- (UMLS (ICD9CM) C0994527) Other endovascular graft repair (of aneurysm) of other vessels =Therapeutic or Preventive Procedure ;
| - 82. Endocrine System Finding
- (UMLS (NCI) C0559306) =Finding
|
- 33. ENDO TRANSMYO REVASCULAR
- [ ] (UMLS (ICD9CM) C1719412) Endoscopic transmyocardial revascularization =Therapeutic or Preventive Procedure
| - 83. Endocrine System Signs and Symptoms
- [Patient complaints, physical findings, laboratory findings referable to the endocrinologic system. ( NCI )] (UMLS (NCI) C1333389) =Sign or Symptom
|
- 34. endo V
- [ ] (UMLS (CSP) C0872163) =Amino Acid, Peptide, or Protein; Enzyme
| - 84. Endocrine Testis
- (UMLS (NCI) C1268152) =Body Part, Organ, or Organ Component
|
- 35. Endobronchial Hamartoma
- (UMLS (NCI) C1333385) =Neoplastic Process
| - 85. endocrine transplantation
- [transference of glands or tissues from the endocrine system, within an individual, between individuals of the same species, or between individuals of different species. ( CSP )] (UMLS (CSP) C0596512) =Therapeutic or Preventive Procedure ;
=endocrine surgery;
transplantation =pancreas grafting;
THYMUS TRANSPLANTATION;
adrenal transplantation;
|
- 36. Endobronchial Leiomyoma
- [A benign smooth muscle neoplasm arising from the endobronchus. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. ( NCI )] (UMLS (NCI) C1333386) =Neoplastic Process
| - 86. ENDOCRINE, METABOLIC AND NUTRITIONAL
- (UMLS (ICPC) C0497395) (ENDOCRINE, METABOLIC AND NUTRITIONAL; (194); (115); (116); (104); (105); (106); (108); (119); (133); (130); (122); (123)) =Classification =International Classification of Primary Care; =boesartige Neubild der Schilddruese; body water dehydration; Diabete mellito; Achterbl verwachte fysiol ontwikk; DIABETES RENALA; Bocio (excl T85 T86); Gicht; Blood Glucose, Low; Cisti del dotto tireoglosso; aliya bamishkal; ABNORMAL LOSS OF WEIGHT; Benign Neoplasm of the Thyroid; Alteracoes do metabolismo lipidico; gush batiroid; Adipositas (BMI >=30); Apetite excessivo; Hipertiroidismo/tireotoxicose; AIKUISEN RUOKINTAONGELMA (POISLUKIEN T06); anoreksia nervoza; Angst v kanker endocriene klieren; Angst and ziekte endo/metab/voed; Altri sint/dist endoc nutr; Altre/non spec neoplasie; Altre anomalie congenite; Exces de poids (IMC
|
- 37. Endobronchial Lipoma
- [A rare benign adipose tissue neoplasm located within the lumen of a bronchus. It is predominantly found in males and usually originates within the fatty tissue between bronchial cartilage. May cause irreversible pulmonary damage distally. Two-thirds of the tumors occur on the right side and most are located on the first three subdivisions of the tracheobronchial tree. ( NCI )] (UMLS (NCI) C0852937) =Neoplastic Process
| - 87. ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES, AND IMMUNITY DISORDERS
- (UMLS (ICD9CM) C0342105) =Disease or Syndrome ;
|
- 38. Endobronchial Mass
- (UMLS (NCI) C0743497) =Disease or Syndrome
| - 88. ENDOCRINE/NERV NEO NOS
- [ ] (UMLS (ICD9CM) C0154134) =Neoplastic Process ;
|
- 39. endocannabinoid
- [endogenous compounds that bind to cannabinoid receptors, frequently neuroactive; chemically different from the plant derived cannabinoids. ( CSP )] (UMLS (CSP) C1172779) endogenous cannabinoid;
=Organic Chemical; Biologically Active Substance ;
=cell communication molecule;
=anandamide | - 89. endocrinologist
- [(en-do-krih-NAH-lo-jist) A doctor who specializes in diagnosing and treating hormone disorders. ( NCI )] (UMLS (NCI) C0259863) =Professional or Occupational Group ;
|
- 40. ENDOCAR CUSHION REP NEC
- [ ] (UMLS (ICD9CM) C0176576) =Therapeutic or Preventive Procedure
| - 90. endocrinology
- [for thorough searching see all RTs and check the Permuted Term Index for similar alpha strings. ( CSP )] (UMLS (CSP) C0014137) =Biomedical Occupation or Discipline ;
=Physiology;
=thyroid function;
hormone regulation/control mechanism;
invertebrate endocrinology;
pancreatic islet function;
|
- 41. ENDOCARD CUSHION DEF NEC
- [ ] (UMLS (ICD9CM) C0029608) =Congenital Abnormality
| - 91. Endocrinology clinic
- (UMLS (HL7) C1552774) =Intellectual Product ;
=Outpatient facility;
=Pediatric endocrinology clinic;
|
- 42. ENDOCARD CUSHION DEF NOS
- [A spectrum of septal defects involving the ATRIUM SEPTUM; VENTRICULAR SEPTUM; and the atrioventricular valves (TRICUSPID VALVE; BICUSPID VALVE). These defects are due to incomplete growth and fusion of the ENDOCARDIAL CUSHIONS which are important in the formation of two atrioventricular canals, site of future atrioventricular valves. ( MSH )] (UMLS (ICD9CM) C0014116) =Congenital Abnormality ;
=congenital heart septum defect;
| - 92. Endocrinology, Diabetes & Metabolism
- (UMLS (HL7) C1555758) =Intellectual Product =Internal Medicine;
|
- 43. ENDOCARD FIBROELASTOSIS
- [condition characterized by hypertrophy of the wall of the left ventricle and conversion of the endocardium into a thick fibroelastic coat, with the capacity of the ventricle sometimes reduced, but often increased. ( CSP )] (UMLS (ICD9CM) C0014117) =Disease or Syndrome ;
=CARDIAC DISORDERS;
cardiomyopathy | - 93. endocytosis
- [the uptake by a cell of material from the environment by invagination of its plasma membrane. ( CSP )] (UMLS (CSP) C0014139) =Cell Function ;
=membrane activity;
=phagocytosis;
pinocytosis;
receptor mediated endocytosis |
- 44. Endocardial
- [innermost layer of the heart, comprised of endothelial cells. ( CSP )] (UMLS (NCI) C0014124) =Tissue ;
=cardiac;
Body Part | - 94. Endocytotic Vesicle
- [OBSOLETE (was not defined before being made obsolete). [GOC:go_curators] ( GO )] (UMLS (NCI) C0887883) =Cell Component ;
|
- 45. Endocardial Neoplasm
- (UMLS (NCI) C1290401) Endocardial Tumor;
Neoplasm of Endocardium;
Neoplasm of the Endocardium;
Tumor of Endocardium;
Tumor of the Endocardium =Neoplastic Process ;
| - 95. endodeoxyribonuclease
- [A group of enzymes catalyzing the endonucleolytic cleavage of DNA. They include members of EC 3.1.21.-, EC 3.1.22.-, EC 3.1.23.- (DNA RESTRICTION ENZYMES), EC 3.1.24.- (DNA RESTRICTION ENZYMES), and EC 3.1.25.-. ( MSH )] (UMLS (CSP) C0014143) =Amino Acid, Peptide, or Protein; Enzyme =deoxyribonuclease;
endonuclease;
Ester Hydrolase;
=deoxyribonuclease I;
restriction endonuclease;
deoxyribonuclease I |
- 46. endocarditis
- [exudative and proliferative inflammatory alterations of the endocardium, characterized by the presence of vegetations on the surface of the endocardium or in the endocardium itself, and most commonly involving a heart valve, but sometimes affecting the inner lining of the cardiac chambers or the endocardium elsewhere; may occur as a primary disorder or as a complication of or in association with another disease. ( CSP )] (UMLS (CSP) C0014118) =Disease or Syndrome ;
=CARDIAC DISORDERS;
=bacterial endocarditis | - 96. endoderm
- [germ layer lying remote from the surface of the embryo that gives rise to internal tissues such as gut. ( CSP )] (UMLS (CSP) C0014144) =Embryonic Structure ;
=germ layer;
|
- 47. Endocarditis in diseases classified elsewhere
- [ ] (UMLS (ICD9CM) C0340345) =Disease or Syndrome ;
| - 97. Endoderm Cell
- [An embryonic cell of the inner layer of three germ layers that forms the yolk sac and gives rise to the epithelium of the alimentary and respiratory tracts and the parenchyma of associated glands. ( NCI )] (UMLS (NCI) C1183500) Endodermal Cell =Cell
|
- 48. ENDOCARDITIS NEC
- [ ] (UMLS (ICD9CM) C0029609) =Disease or Syndrome
| - 98. Endodermal Sinus Neoplasm
- [A non-seminomatous malignant germ cell tumor composed of primitive germ cells. It is the most common malignant germ cell tumor in the pediatric population. It occurs in the infant testis, ovary, sacrococcygeal region, vagina, uterus, prostate, abdomen, liver, retroperitoneum, thorax and pineal/third ventricle. The tumor mimics the yolk sac of the embryo and produces alpha-fetoprotein (AFP). Treatment includes: surgical resection, radiation and chemotherapy. This tumor is very responsive to chemotherapy regimens that include cisplatinum. ( NCI )] (UMLS (NCI) C0014145) =Neoplastic Process ;
=Malignant Mesonephroma;
|
- 49. ENDOCARDITIS NOS
- [ ] (UMLS (ICD9CM) C0264865) =Disease or Syndrome ;
| - 99. Endodermal Sinus Neoplasm of Mediastinum
- (UMLS (NCI) C1334683) Endodermal Sinus Neoplasm of the Mediastinum;
Endodermal Sinus Tumor of Mediastinum;
Endodermal Sinus Tumor of the Mediastinum;
Mediastinal Endodermal Sinus Neoplasm;
Mediastinal Endodermal Sinus Tumor;
Mediastinal Yolk Sac Neoplasm;
Mediastinal Yolk Sac Tumor;
Yolk Sac Neoplasm of Mediastinum;
Yolk Sac Neoplasm of the Mediastinum;
Yolk Sac Tumor of Mediastinum;
Yolk Sac Tumor of the Mediastinum =Neoplastic Process |
- 50. Endocardium
- (UMLS (HL7) C1546617) =Intellectual Product =Specimen Source Codes;
| - 100. Endodermal Sinus Neoplasm of Ovary
- (UMLS (NCI) C0346188) =Neoplastic Process
|
home
